Insecticides (India) Limited (IIL) has formally announced the launch of GRANUVIA™, a next-generation insecticide engineered specifically for paddy cultivation. This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

GRANUVIA™ is a future-ready solution designed to combat two major threats in paddy farming: the brown plant hopper (BPH) and the stem borer. According to the company, the product provides long-duration control of BPH for up to 60 days when applied within the recommended window of 30–35 days after transplanting. Additionally, it offers up to two weeks of protection against stem borer, specifically for dead heart management. The product utilizes a simple broadcasting application method—compatible with common practices like mixing with sand or urea—to ensure ease of use for farmers. This insecticide was developed by Corteva Agriscience and is exclusively supplied to IIL under the GRANUVIA™ brand name.

Insecticides (India) Limited is a prominent Indian crop protection and nutrition company with an extensive portfolio of over 21 technical products and 125+ formulation products. The company operates a fully integrated manufacturing setup, including two technical synthesis plants and six formulation plants. In early 2026, the company underwent a major internal restructuring of its promoter shareholding involving the transfer of 67.65% of its stake to newly formed family trusts, such as the Sanskriti Family Trust, to streamline succession planning. Furthermore, in March 2026, the company received a patent for a synergistic insecticidal combination of Diafenthiuron and Acetamiprid.

For the quarter ended December 31, 2025, Insecticides (India) reported revenue of ₹385.92 crore, representing a 7.77% increase compared to the same period in the previous year. The company’s net profit for this period was ₹10.49 crore, which marked a decline of 39.61% year-on-year. Regarding institutional holdings, HDFC Small Cap Fund is a notable investor in the company, holding approximately 8.93% of the share capital as of the quarter ended March 2026.